Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03076372
Title A Study Evaluating MM-310 in Patients With Solid Tumors
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merrimack Pharmaceuticals
Indications

transitional cell carcinoma

gastroesophageal junction adenocarcinoma

head and neck squamous cell carcinoma

triple-receptor negative breast cancer

lung small cell carcinoma

ovarian cancer

pancreatic ductal adenocarcinoma

sarcoma

stomach carcinoma

endometrial carcinoma

esophageal carcinoma

lung non-small cell carcinoma

Therapies

MM-310

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.